Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy
Advancing the timing of ICI administration is associated with an increased incidence of ≥grade 2 RP following cCRT in patients with stage III unresectable NSCLC.
Authors
- Xiaoshuan Liang
- Pengwei Li
- Yiwei Qin (ORCID: https://orcid.org/0009-0001-1871-4699)
- You Mo (ORCID: https://orcid.org/0000-0001-5283-0741)
- Dawei Chen (ORCID: https://orcid.org/0000-0002-6762-7997)
- Jinming Yu
Institutions
- Weifang Medical University (CN)
- Shandong University (CN)
- Shantou University (CN)
- Shandong Tumor Hospital (CN)
- First Affiliated Hospital of Shantou University Medical College (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Cancers
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3390/cancers17101711
- Citations
- 3
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- National Science and Technology Major Project